Pyxis Innovations Inc Amway
Starting in 2003, Alticor purchased a controlling interest in Interleukin Genetics (currently 58 percent) as part of its long-term vision to be able to offer personalised health solutions and products, particularly nutrition and supplementation, that are customised or 'personalised' to each person's needs.
Genetics of Interleukin
- A personalised health company that focuses on genetics.
0 comments: